Upcoming Event: China Clinical Trials Leaders Summit 2017
3/14/2017
Event: China
Clinical Trials Leaders Summit 2017
Date:
June
29, 2017
Venue: Parkyard
Hotel, Shanghai, China
Weblink: www.clinicaltrialsleaders.com
Contact: Marketing Department
Tel: +86 21
3160 2153
Email: marketing@wbfgroup.com
Over the years, China
has increasingly become the hotbed and destination for the clinical research.
From one side, increasingly global pharmaceutical companies have recognized the
importance and advantages to integrate China into the global early and late
phase clinical development but also meanwhile the china clinical research
markets are further driven and facilitated by the rapidly transforming China
Local R&D Innovation.
A part of our highly
successful Clinical Trials series, the event, which attracts over 150
attendees, will build upon CTLCS 2017 and examine partnerships and outsourcing
strategies; key regulatory changes and the effects these have had on china
market access; best practice techniques in clinical operations; Data Integrity,
Quality & Risk Management; and also address the need to adopt Innovative
Technology to ensure safety, transparency and quality as well as the hurdles of
Oncology Drug Development ,Biologics & Biosimilar so as to keep up to date
with the pace of growth in the region and maintain the clinical trials boom in
Asia.
With over 20 speakers
and estimation to bring over 150 clinical professionals, the key congress
topics will cover:
-
Regulation,Outlook and Trend
-
Compliance, Quality and Data Integrity
-
Strategic Partnerships & Clinical Outsourcing
-
Patient Centric, Site Selection and Project Management
-
Innovation ,Technology and Analytics
-
Oncology Drug Development ,Biologics & Biosimilar
On behalf of the
committee, we sincerely hope primary discussions, topics and invitees would
come across your scientific and strategic interests and the whole summit will
be consisted of keynote speeches, panel/roundtable discussions, open Q&A
sessions, booth and poster exhibition and guided networking sessions for all
professionals and management who are working for the drug development programs
in china.